Brightsurf Science News & Current Events

September 05, 2020
New drug shown to improve bone growth in children with achondroplasia
A phase three global clinical trial led by the Murdoch Children's Research Institute (MCRI) has shown that the drug vosoritide restores close-to-average bone growth rates of children with achondroplasia, the most common form of dwarfism.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.